Wednesday, April 27, 2022

A review of medical device regulations in India, comparison with European Union and way-ahead

                     

Manu M, Anand G. A review of medical device regulations in India, comparison with European Union and way-ahead. Perspect Clin Res. 2022 Jan-Mar;13(1):3-11.

Abstract:

        Indian healthcare sector is a fast-growing industry which is expected to reach $280 billion by 2025. Medical devices market in India is one of the top 20 medical device markets in the world. It is currently valued at $5.2 billion and is expected to reach $50 billion by 2025. However, India does not manufacture many devices indigenously and still imports approximately 70% of its medical devices. Manufacturing and monitoring of medical devices are highly regulated activities. In India, there were no specific medical device regulations and devices were regulated under the Drugs and Cosmetics Act, 1940. To fulfill this gap, Central Drug Standard Control Organization released Indian Medical Device Rules, 2017, which are the new regulations for medical devices in India. Keeping pace with the requirements, these were amended as Medical Devices (Amendment) Rules, 2020, which has come into force in April 2020. These rules cover various aspects of device related regulations, including classification, registration, manufacturing and import, labeling, sales, and postmarket requirements, etc. The rules are a positive step and encompass most of the European Union (EU) approval process, which mandates that the devices are safe and performs its intended function. However, with rapid advancements in medical device technology, much is desired in clarity and revamping of the current regulatory system to harmonize standards to be in-line with advanced regulations like EU.

Manu M, Anand G. A review of medical device regulations in India, comparison with European Union and way-ahead. Perspect Clin Res. 2022 Jan-Mar;13(1):3-11. 

doi: 10.4103/picr.PICR_222_20. Epub 2021 Jul 12. PMID: 35198422; PMCID: PMC8815674.

Affiliations:

 1: Department of Medical Writing, Tata Consultancy Services Limited, Mumbai, Maharashtra, India.

References:

    1. Deloitte, NATHEALTH Medical devices making in India-a leap for Indian healthcare. 2016. [Last accessed on 2021 Mar 04]. Available from: https://www2.deloitte.com/content/dam/Deloitte/in/Documents/life-science... .
    1. India – Overview of Medical Device Industry and Healthcare Statistics. Available via EMERGO. 2016. Jul, [Last accessed on 2020 Jun 30]. Available from: https://www.emergobyul.com/resources/market-india .
    1. Union Budget of India 2020-21, Rebuilding Momentum. Available via PricewaterhouseCoopers Private Limited. 2020. Feb, [Last accessed on 2020 Jun 20]. Available from: https://www.pwc.in/assets/pdfs/budget/2020/pwc-union-budget-analysis.pdf .
    1. Markan S, Verma Y. Indian medical device sector: Insights from patent filing trends. BMJ Innov. 2017;3:167–75.
    1. Medical Device Rules, 2017: Ministry of Health and Family Welfare, Government of India. Available via CDSCO. [Last accessed on 2020 Jun 08]. Available from: https://cdsco.gov.in/opencms/opencms/en/Medical-Device-Diagnostics/Medic...
    1. Medical Devices (Amendment) Rules, 2020: Ministry of Health and Family Welfare, Government of India. Available via CDSCO. [Last accessed on 2020 Jun 08]. Available from: https://cdsco.gov.in/opencms/opencms/en/Medical-Device-Diagnostics/Medic...
    1. European Commission. Medical Device Regulation (MDR). Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC. [Last accessed on 2020 Jun 20]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0745 .
    1. European Commission. In Vitro Diagnostic Regulation (IVDR) – Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro Diagnostic Medical Devices and Repealing Directive 98/79/EC and Commission Decision 2010/227/EU. [Last accessed on 2020 Jun 08]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0746... .
    1. [Last accessed on 2021 Mar 03];European Commission. Getting ready for the new regulations. Available from https://ec.europa.eu/health/md_newregulations/getting_ready_en .
    1. Shukla S, Gupta M, Pandit S, Thomson M, Shivhare A, Kalaiselvan V, et al. Implementation of adverse event reporting for medical devices, India. Bulletin of the World Health Organization. 2020;98:206. - PMC PubMed
    1. [Last accessed on 2020 Jun 30];Strengthening of Materiovigilance Programme of India (MvPI) in the country; Letter from DCGI to all states drugs authorities (26 November 2019). Available via CDSCO. Available from: https://cdsco.gov.in/opencms/opencms/en/Medical-Device-Diagnostics/Medic...
    1. [Last accessed on 2020 Jun 18];Directorate General of Health Services. Ministry of Health & Family Welfare, Government of India (Product recall). CDSCO. Available from: https://cdsco.gov.in/opencms/opencms/en/consumer/Product-Recall/
    1. Medical Device Clinical Evaluation Working Group Clinical evaluation. Doc no. IMDRF/MDCE WG/N56 FINAL:2019. International Medical Device Regulators Forum (IMDRF) [Last accessed on 2021 Mar 03]. Available from: http://www.imdrf.org/docs/imdrf/final/technical/imdrf-tech-191010-mdce-n... .
    1. European Commission. EUDAMED - European Database on Medical Devices. [Last accessed on 2021 Mar 03]. Available from: https://ec.europa.eu/tools/eudamed/#/screen/home .

No comments:

Post a Comment

Personalized Diagnostics vs. Prescription-Based Diagnostics: A Scientific and Critical Review

  Introduction The healthcare landscape is evolving rapidly, with personalized diagnostics emerging as a transformative approach in contrast...